These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7086846)
1. Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids. Consroe P; Martin AR; Fish BS J Med Chem; 1982 May; 25(5):596-9. PubMed ID: 7086846 [TBL] [Abstract][Full Text] [Related]
2. Rabbit behavioral model of marijuana psychoactivity in humans. Consroe P; Fish BS Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517 [TBL] [Abstract][Full Text] [Related]
4. Models to predict cannabinoid-induced disturbances. Edery H Arch Toxicol Suppl; 1983; 6():91-103. PubMed ID: 6578751 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400 [TBL] [Abstract][Full Text] [Related]
6. A cannabinoid with cardiovascular activity but no overt behavioral effects. Adams MD; Earnhardt JT; Martin BR; Harris LS; Dewey WL; Razdan RK Experientia; 1977 Sep; 33(9):1204-5. PubMed ID: 891878 [TBL] [Abstract][Full Text] [Related]
7. The ontogeny of delta-9-tetrahydrocannabinol responsiveness in the rabbit. Fish BS; Consroe P Dev Psychobiol; 1983 Mar; 16(2):147-58. PubMed ID: 6299864 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids. Martin BR; Compton DR; Little PJ; Martin TJ; Beardsley PM NIDA Res Monogr; 1987; 79():108-22. PubMed ID: 2830532 [TBL] [Abstract][Full Text] [Related]
9. Cannabis: pharmacology and toxicology in animals and humans. Adams IB; Martin BR Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919 [TBL] [Abstract][Full Text] [Related]
10. The effects of delta 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes. Little PJ; Martin BR Life Sci; 1991; 48(12):1133-41. PubMed ID: 1848340 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. Tanda G; Goldberg SR Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346 [TBL] [Abstract][Full Text] [Related]
12. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012 [TBL] [Abstract][Full Text] [Related]
13. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. Beardsley PM; Scimeca JA; Martin BR J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218 [TBL] [Abstract][Full Text] [Related]
14. Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats. Yamaguchi T; Shoyama Y; Watanabe S; Yamamoto T Brain Res; 2001 Jan; 889(1-2):149-54. PubMed ID: 11166698 [TBL] [Abstract][Full Text] [Related]
16. Some 9-hydroxycannabinoid-like compounds. Synthesis and evaluation of analgesic and behavioral properties. Wilson RS; May EL; Dewey WL J Med Chem; 1979 Jul; 22(7):886-8. PubMed ID: 448688 [TBL] [Abstract][Full Text] [Related]